Ascorbic Acid, Thiamine, Riboflavin, Niacinamide, Pyridoxine, Folic Acid, Cobalamin, Biotin, Pantothenic Acid · ASCORBIC ACID 100 mg/1; THIAMINE MONONITRATE 1.5 mg/1; RIBOFLAVIN 1.7 mg/1; NIACINAMIDE 20 mg/1; PYRIDOXINE HYDROCHLORIDE 10 mg/1; FOLIC ACID 1 mg/1; COBALAMIN 6 ug/1; BIOTIN 300 ug/1; CALCIUM PANTOTHENATE 10 mg/1 · Tablet, Coated · Oral · Hillestad Pharmaceuticals USA
NDC 10542-0010-10 · 100 TABLET, COATED in 1 BOTTLE, PLASTIC · UNAPPROVED DRUG OTHER · View full market →
Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $0.1629 per unit over the past year. Put together: worth watching — several of the pressures that precede supply trouble are present at once.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.
The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.
The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Hillestad Pharmaceuticals USA | ASCORBIC ACID 100 mg/1; THIAMINE MONONITRATE 1.5 mg/1; RIBOFLAVIN 1.7 mg/1; NIACINAMIDE 20 mg/1; PYRIDOXINE HYDROCHLORIDE 10 mg/1; FOLIC ACID 1 mg/1; COBALAMIN 6 ug/1; BIOTIN 300 ug/1; CALCIUM PANTOTHENATE 10 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Hillestad Pharmaceuticals USA | ASCORBIC ACID 100 mg/1; THIAMINE MONONITRATE 300 ug/1; RIBOFLAVIN 10 mg/1; NIACINAMIDE 6 ug/1; PYRIDOXINE HYDROCHLORIDE 1 mg/1; FOLIC ACID 20 mg/1; COBALAMIN 10 mg/1; BIOTIN 1.7 mg/1; CALCIUM PANTOTHENATE 1.5 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Hillestad Pharmaceuticals USA | ASCORBIC ACID 100 mg/1; BIOTIN 300 ug/1; CALCIUM PANTOTHENATE 10 mg/1; COBALAMIN 6 ug/1; FOLIC ACID 1 mg/1; NIACINAMIDE 20 mg/1; PYRIDOXINE HYDROCHLORIDE 10 mg/1; RIBOFLAVIN 1.7 mg/1; THIAMINE MONONITRATE 1.5 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Dialyvite — NDC 10542-0010-10," retrieved September 3, 2026, https://drugdashboards.com/drug/10542001010.
Free to cite with attribution — see how the data is put together.